CHE logo

Chemed Corp (CHE)

$549.45

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CHE

Market cap

$7.15B

EPS

20.87

P/E ratio

25.1

Price to sales

2.52

Dividend yield

0.51%

Beta

0.498904

Price on CHE

Previous close

$548.20

Today's open

$550.69

Day's range

$545.76 - $553.54

52 week range

$365.21 - $562.24

Profile about CHE

CEO

Kevin J. McNamara

Employees

15811

Headquarters

Cincinnati, OH

Exchange

New York Stock Exchange

Shares outstanding

13014915

Issue type

Common Stock

CHE industries and sectors

Healthcare

Healthcare Providers & Services

News on CHE

Chemed: 3 Key Takeaways for Long-Term Investors

Chemed spent $96 million reacquiring Roto-Rooter franchise territories during 2026. VITAS Healthcare increased average daily patient census by 9.4%.

news source

The Motley Fool • 15 hours ago

news preview

Here's Why Chemed (CHE) is a Strong Momentum Stock

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Nov 10, 2026

news preview

Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript

Chemed Corporation (CHE) Presents at 2026 UBS Global Healthcare Conference Transcript

news source

Seeking Alpha • Nov 9, 2026

news preview

Chemed Corporation Declares Quarterly Dividend of 70 Cents

CINCINNATI, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has declared a quarterly cash dividend of 70-cents per share on the Company's capital stock, payable on December 4, 2026, to shareholders of record as of November 16, 2026. This is equal to the dividend paid in September 2026.

news source

GlobeNewsWire • Nov 6, 2026

news preview

Chemed Corporation to Present at the UBS 2026 Global Healthcare Conference

CINCINNATI, Nov. 02, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the UBS 2026 Global Healthcare Conference on Monday, November 9, 2026, at approximately 8:45 a.m. (ET) at the PGA National Resort in Palm Beach Gardens, Florida.

news source

GlobeNewsWire • Nov 2, 2026

news preview

Why Chemed (CHE) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

news source

Zacks Investment Research • Nov 2, 2026

news preview

What Chemed (CHE) Said on Its Q3 Earnings Call

Chemed NYSE: CHE reported higher third-quarter revenue and adjusted earnings as growth at its VITAS hospice business offset margin pressure at Roto-Rooter from customer-acquisition and fuel costs.

news source

MarketBeat • Oct 29, 2026

news preview

Chemed Corporation (CHE) Q3 2026 Earnings Call Transcript

Chemed Corporation ( CHE ) Q3 2026 Earnings Call October 28, 2026 10:00 AM EDT Company Participants Holley Schmidt - Vice President & Assistant Controller Kevin McNamara - CEO, President & Director Michael Witzeman - Executive VP, Controller, Principal Accounting Officer & CFO Joel Wherley - Executive VP and President & CEO of VITAS Healthcare Conference Call Participants Brian Tanquilut - Jefferies LLC, Research Division Joanna Gajuk - BofA Securities, Research Division Benjamin Hendrix - RBC Capital Markets, Research Division Albert Rice - UBS Investment Bank, Research Division Presentation Operator Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Chemed Corporation Third Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, this conference call is being recorded.

news source

Seeking Alpha • Oct 28, 2026

news preview

Chemed Reports Third-Quarter 2026 Results

CINCINNATI, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation's largest providers of end-of-life care, and Roto-Rooter, the nation's largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its third quarter ended September 30, 2026, versus the comparable prior-year period. Results for Quarter Ended September 30, 2026 Consolidated operating results: Revenue increased 10.6% to $690.9 million GAAP Diluted Earnings-per-Share (EPS) of $5.45, an increase of 22.2% Adjusted Diluted EPS of $6.75, an increase of 28.1% VITAS segment operating results: Net Patient Revenue of $457.4 million, an increase of 12.2% Average Daily Census (ADC) of 24,428, an increase of 9.4% Admissions of 18,995, an increase of 7.2% Net Income, excluding certain discrete items, of $70.8 million, an increase of 44.7% Adjusted EBITDA, excluding Medicare Cap, of $92.5 million, an increase of 31.4% Adjusted EBITDA margin, excluding Medicare Cap, of 20.2%, an increase of 318-basis points Roto-Rooter segment operating results: Revenue of $233.5 million, an increase of 7.5% Net Income, excluding certain discrete items, of $33.3 million, a decline of 1.8% Adjusted EBITDA of $48.2 million, a decline of 2.5% Adjusted EBITDA margin of 20.6%, a decline of 213-basis points VITAS VITAS net revenue was $457.4 million in the third quarter of 2026, which is an increase of 12.2% when compared to the prior-year period.

news source

GlobeNewsWire • Oct 27, 2026

news preview

Chemed (CHE) Tops Q3 Earnings and Revenue Estimates

Chemed (CHE) came out with quarterly earnings of $6.75 per share, beating the Zacks Consensus Estimate of $6.39 per share. This compares to earnings of $5.27 per share a year ago.

news source

Zacks Investment Research • Oct 27, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Chemed Corp

Open an M1 investment account to buy and sell Chemed Corp commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CHE on M1